Radium-223 therapy in symptomatic metastatic castrate resistant prostate cancer (mCRPC) – sequential use post-abiraterone/prednisolone

2019 
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    0
    Citations
    NaN
    KQI
    []